-
Glue Grant
Distance: 0.2 Mi55 Fruit St
02114-2696 Boston -
Massachusetts General Hospital
Distance: 0.2 Mi55 Fruit St
02114-2621 Boston -
Brown Sardina, Inc
Distance: 0.4 Mi129 S Street Fl 6
02111 Boston -
Vincent Club
Distance: 0.5 Mi71 Brimmer St
02108-3321 Boston -
Mgh Institute-Health Profsns
Distance: 1.1 Mi36 1st Ave
2129 Charlestown
Description
CNfAD is a virtual center that spans the Harvard Medical School and affiliated hospitals, including Brigham and Women's Hospital (BWH), Children's Hospital Boston (CHB), Dana Farber Cancer Institute (DFCI), Massachusetts General Hospital (MGH), and Beth Israel Deaconess Medical Center (BIDMC). CNfAD is directed by Dr. James Gusella, a molecular geneticist whose research over the last 25 years has focused on both neurodegenerative and neurodevelopmental disorders including neurofibromatosis types 1 (NF1) and 2 (NF2), and related disorders among the phakomatoses, such as tuberous sclerosis (TSC) and von Hippel Lindau (VHL) disease. Dr. Robert Martuza, an expert in the neurosurgical aspects of NF1 and NF2, is Associate Director of the CNfAD. The CNfAD faculty comprises a multidisciplinary collection of talented investigators and clinicians with a noteworthy track record of accomplishments in basic and applied NF research and clinical care, including Dr. Mira Irons at Children's Hospital (Associate Chief, Division of Genetics and Director of Neurofibromatosis Program), Dr. Mark Kieran from Dana Farber Cancer Institute (Clinical Director of Pediatric Medical Neuro-oncology), and Dr. Mia MacCollin at Massachusetts General Hospital (Clinical Director of MGH NF Clinic). Please visit our Affiliated Members web page to learn more about our collaborators and their current research efforts.